Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2793)
  2. Meeting Abstract (2524)
  3. Review (119)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5690)
  2. Department of Medicine (5680)
  3. GSK Faculty (1658)
  4. Human Oncology and Pathogenesis Program (1157)
  5. Department of Pathology and Laboratory Medicine (1129)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (785)
  4. Dean Bajorin (663)
  5. Michael Morris (587)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (199)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (121)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (689)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (394)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (302)

More Publishers

Results (5690)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing
    Meeting Abstract

    Truong, H.; Breen, K.; Kemel, Y.; Lenis, A. T.; Reisz, P.; Benfante, N.; Ehdaie, B.; Touijer, K. A.; Laudone, V. P.; Scardino, P. T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Disparities in pan-cancer patients undergoing germline cancer risk assessment by self-reported race/ethnicity and ancestry
    Meeting Abstract

    Liu, Y. L.; Maio, A.; Kemel, Y.; Salo-Mullen, E. E.; Sheehan, M.; Tejada, P. R.; Trottier, M.; Fleischut, M. H.; Latham, A.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A nutritional management algorithm in older patients with locally advanced esophageal cancer
    Meeting Abstract

    Moy, R. H.; Sabwa, S.; Maron, S. B.; Shcherba, M.; Apollo, A. J.; Janjigian, Y. Y.; Ku, G. Y.; Tew, W. P.; Ilson, D. H.; Won, E.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Documentation of goals of care (GOC) by medical oncologists is associated with improved oncology patient end-of-life (EOL) care outcomes
    Meeting Abstract

    Xiao, H.; Riley, M.; Donopria, R.; Martin, S.; Nelson, J. E.; Epstein, A. S.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Provision of subspecialized expert oncology (SEO) opinions using Navya Cancer Data Model (NCDM), a technology-based platform: Prospective study to facilitate access to care
    Meeting Abstract

    Traina, T. A.; Kantoff, P. W.; Matasar, M. J.; Dunn, L.; Friedman, C. F.; Voss, M. H.; Seidman, A. D.; Cahlon, O.; Zauderer, M. G.; Manship, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • VEGF inhibition reduces intracranial edema following SRS of brain metastases from renal cell carcinoma
    Meeting Abstract

    Ma, J.; Pike, L. R. G.; Kotecha, R. R.; Carlo, M.; Imber, B. S.; Yamada, Y.; Moss, N.; Beal, K.
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib (N+C) vs sunitinib for advanced renal cell carcinoma (aRCC): Outcomes by baseline disease characteristics in the phase 3 CheckMate 9ER trial
    Meeting Abstract

    Pook, D.; Powles, T.; Burotto, M.; Bourlon, M. T.; Hsieh, J. J.; Basso, U.; Shah, A. Y.; Suarez, C.; Porta, C.; Barrios, C.; more...
    Asia-Pacific Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase 2/3 prospective multicenter study of the diagnostic accuracy of prostate specific membrane antigen PET/CT with (18)F-DCFPyL in prostate cancer patients (OSPREY)
    Journal Article

    Pienta, K. J.; Gorin, M. A.; Rowe, S. P.; Carroll, P. R.; Pouliot, F.; Probst, S.; Saperstein, L.; Preston, M. A.; Alva, A. S.; Patnaik, A.; more...
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • Quantification of metastatic prostate cancer whole-body tumor burden with (18)F-FDG PET parameters and associations with overall survival after first-line abiraterone or enzalutamide: A single-center retrospective cohort study
    Journal Article

    Wibmer, A. G.; Morris, M. J.; Gonen, M.; Zheng, J.; Hricak, H.; Larson, S.; Scher, H. I.; Vargas, H. A.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Dermatologic infections in cancer patients treated with checkpoint inhibitors
    Journal Article

    Do, M. H.; Barrios, D. M.; Phillips, G. S.; Postow, M. A.; Warner, A. B.; Rosenberg, J. E.; Noor, S. J.; Markova, A.; Lacouture, M. E.
    Journal of the American Academy of Dermatology (2021)

    Fulltext@MSK | Save